reports

Huize Holding Limited Reports Unaudited Financial Results for the Second Half and Full Year 2025

SHENZHEN, China, March 27, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading…

2 weeks ago

Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

Product sales and commercial rights revenues in 2025 increased 90% year-over-year to US$82.1 million (RMB574.1 million)Sales of Olverembatinib increased 81% year-over-year…

2 weeks ago

Nexteer Reports 2025 Year End Results

Continues Above-Market Growth with Expanding MarginsAUBURN HILLS, Mich., March 24, 2026 /PRNewswire/ -- Nexteer Automotive (HK 1316) today reported financial…

2 weeks ago

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

March 20, 2026 16:30 ET  | Source: Zevra Therapeutics BOSTON, March 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS:…

3 weeks ago

GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth

Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net profit: US$230.3 million, +285.0% year-on-yearBusiness Units' PerformanceGenScript Life…

3 weeks ago

Crescel Reports Positive Randomized Controlled Trial Results for Biobotanical Skin Renewal Cream in Rosacea

Study Shows Greater Clinical Improvement vs. Metronidazole-Based Standard of Care with Favorable TolerabilityMIAMI BEACH, Fla., March 20, 2026 /PRNewswire/ -- Crescel LLC,…

3 weeks ago

Cango Inc. Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results

DALLAS, March 16, 2026 /PRNewswire/ -- Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop an…

3 weeks ago

VitalHub Reports Fourth Quarter 2025 Results

Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 millionTotal Revenue up 52% YoY to $31.4 millionAdjusted EBITDA⁽¹⁾ up 47%…

3 weeks ago

Eupraxia Pharmaceuticals Reports Fourth Quarter 2025 Financial Results

March 12, 2026 21:03 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

4 weeks ago